
CHRN P/E Ratio
P/E Ratio as of May 5, 2026: -2.45
Average-2.06
Median-2.12
Minimum-2.45
Maximum-1.58
-2.45
0.59 (31.72%)past month
The P/E ratio for CHRN is -2.45 as of May 5, 2026. This represents a increase of 107.63% compared to its 12-month average P/E ratio of -1.18. A higher P/E ratio suggests that investors expect strong future earnings growth, while a lower P/E ratio may indicate a potentially undervalued stock or slowing growth.
Ekso Bionics Holdings Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Ekso Bionics Holdings Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Ekso Bionics Holdings Inc to industry peers.
Ekso Bionics Holdings Inc P/E Ratio Formula = Stock Price ÷ Earnings Per Share (EPS)
Ekso Bionics Holdings Inc’s P/E ratio represents the valuation of the company based on its earnings. It’s calculated by dividing the company’s latest stock price by its diluted earnings per share (EPS) over the past 12 months. The P/E ratio helps investors assess how much they are paying for each dollar of earnings, offering valuable insights when comparing Ekso Bionics Holdings Inc to industry peers.
CHRN P/E Ratio Insights
See Ekso Bionics Holdings Inc’s latest P/E ratio, historical trends, and valuation insights with AI-powered fundamental data and custom analysis.
Start investing in CHRN
Order type
Buy in
Order amount
Est. shares
0 shares
CHRN P/E Ratio Historic Data
| Date | Stock price | P/E ratio |
|---|---|---|
| May 1, 2026 | $11.79 | -2.19 |
| Apr 1, 2026 | $10.65 | -2.10 |
| Mar 2, 2026 | $10.23 | -2.02 |
| Feb 2, 2026 | $9.37 | -1.68 |
| Jan 2, 2026 | $7.84 | -1.41 |
CHRN End of Year P/E Ratio
| Date | P/E ratio | Change |
|---|---|---|
| 2026 | -2.45 | +58.06% |
| 2025 | -1.55 | +44.86% |
| 2024 | -1.07 | -52.02% |
| 2023 | -2.23 | +120.79% |
| 2022 | -1.01 | -66.56% |
| 2021 | -3.02 | — |
FAQs About Ekso Bionics Holdings Inc (CHRN) P/E ratio
The latest P/E ratio of CHRN is -2.45, as of May 5, 2026. This is calculated based on its current stock price and earnings per share (EPS).
Ekso Bionics Holdings Inc’s last 12-month average P/E ratio is -1.18, compared to its current P/E ratio of -2.45. This reflects a increase of 107.63%.
Ekso Bionics Holdings Inc’s current P/E ratio of -2.45 is higher than its last 12-month average P/E of -1.18. A higher P/E can indicate strong future growth expectations, while a lower P/E might suggest undervaluation.
Ekso Bionics Holdings Inc’s average P/E ratio over the last 3 years is -1.25. Comparing this to the current P/E helps assess recent valuation trends and whether the stock is trading above or below its mid-term historical range.
Ekso Bionics Holdings Inc’s average P/E ratio over the last 5 years is -1.77. A deviation from this historical average may indicate shifts in growth expectations, profitability, or broader market conditions affecting valuation.